Scholarlink

<p>Melanoma, a significant global health challenge, is characterized by high metastatic potential and mortality. This review aims to provide an in-depth analysis of recent advancements in theragnostic materials for melanoma and non-melanoma skin cancers. We discuss the development of activatable probes targeting biomarkers like tyrosinase, hydrogen peroxide, and reactive oxygen species, which offer superior photostability, specificity, and deep tissue penetration. Dual-locked designs further enhance tumour selectivity. Innovations in near-infrared (NIR) molecular imaging, using organic fluorophores like BODIPY, cyanine, and rhodamine, enable non-invasive, real-time tumour visualization. Polymeric nanoparticles, microneedle patches, hydrogels, and semiconducting polymer nanodots improve stability, controlled release, and skin penetration, making them critical for both diagnosis and therapy. Hybrid organic-inorganic systems combine the targeting precision of organic dyes with the enhanced photothermal and photodynamic properties of inorganic materials, enabling multimodal imaging and therapeutic synergy. Despite these advancements, challenges such as off-target activation, rapid clearance, aggregation, and long-term biosafety must be addressed to optimize these materials for clinical applications in skin cancer theragnostic.</p><p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Engineering organic, inorganic, carbon, and hybrid materials for skin cancer theragnostic: a focus on melanoma and non-melanoma

  • 期刊论文

  • 发表日期：

    2026年3月24日

查看全文
  • Pachaiyappan Murugan,
  • Vijayapoopathi Singaravel,
  • Chitrarasu Manikandan,
  • Loganathan Praburaman,
  • Meivelu Moovendhan,
  • Kirubakaran Dharmalingam,
  • Shi-Yong Liu

摘要

Melanoma, a significant global health challenge, is characterized by high metastatic potential and mortality. This review aims to provide an in-depth analysis of recent advancements in theragnostic materials for melanoma and non-melanoma skin cancers. We discuss the development of activatable probes targeting biomarkers like tyrosinase, hydrogen peroxide, and reactive oxygen species, which offer superior photostability, specificity, and deep tissue penetration. Dual-locked designs further enhance tumour selectivity. Innovations in near-infrared (NIR) molecular imaging, using organic fluorophores like BODIPY, cyanine, and rhodamine, enable non-invasive, real-time tumour visualization. Polymeric nanoparticles, microneedle patches, hydrogels, and semiconducting polymer nanodots improve stability, controlled release, and skin penetration, making them critical for both diagnosis and therapy. Hybrid organic-inorganic systems combine the targeting precision of organic dyes with the enhanced photothermal and photodynamic properties of inorganic materials, enabling multimodal imaging and therapeutic synergy. Despite these advancements, challenges such as off-target activation, rapid clearance, aggregation, and long-term biosafety must be addressed to optimize these materials for clinical applications in skin cancer theragnostic.